Have a personal or library account? Click to login
In silico selection approach to develop DNA aptamers for a stem-like cell subpopulation of non-small lung cancer adenocarcinoma cell line A549 Cover

In silico selection approach to develop DNA aptamers for a stem-like cell subpopulation of non-small lung cancer adenocarcinoma cell line A549

Open Access
|Mar 2018

References

  1. Shigdar S, Luczo J, Wei MQ, Bell R, Danks A, Liu K, <em>et al</em>. Aptamer therapeutics: the 21st century’s magic bullet of nanomedicine. <em>Open Conf Proc J</em> 2010; <bold>1</bold>: 118-24. <pub-id pub-id-type="doi"><a href="https://doi.org/10.2174/22102892010010100118" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2174/22102892010010100118</a></pub-id>
  2. Baird GS. Where are all the aptamers? <em>Am J Clin Pathol</em> 2010; <bold>134</bold>: 529-31. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1309/AJCPFU4CG2WGJJKS" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1309/AJCPFU4CG2WGJJKS</a></pub-id>
  3. Šmuc T, Ahn IY, Ulrich H. Nucleic acid aptamers as high affinity ligands in biotechnology and biosensorics. <em>J Pharm Biomed Anal</em> 2013; <bold>81-82</bold>: 210-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1016/j.jpba.2013.03.014" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jpba.2013.03.014</a></pub-id>
  4. Zhou J, Rossi JJ. Cell-specific aptamer-mediated targeted drug delivery. <em>Oligonucleotides</em> 2011; <bold>21</bold>: 1-10. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1089/oli.2010.0264" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1089/oli.2010.0264</a></pub-id>
  5. Ulrich H, Wrenger C. Disease-specific biomarker discovery by aptamers. <em>Cytometry A</em> 2009; <bold>75</bold>: 727-33. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/cyto.a.20766" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/cyto.a.20766</a></pub-id>
  6. Nery AA, Wrenger C, Ulrich H. Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents. <em>J Sep Sci</em> 2009; <bold>32</bold>: 1523-30. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/jssc.200800695" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/jssc.200800695</a></pub-id>
  7. Ni S, Yao H, Wang L, Lu J, Jiang F, Lu A, <em>et al</em>. Chemical modifications of nucleic acid aptamers for therapeutic purposes. <em>Int J Mol Sci</em> 2017; <bold>pii: E1683</bold>. <pub-id pub-id-type="doi"><a href="https://doi.org/10.3390/ijms18081683" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/ijms18081683</a></pub-id>.
  8. Ulrich H, Tárnok A. Flow cytometry detection of circulating tumor cells: achievements and limitations as prognostic parameters. <em>Cytometry A</em> 2014; <bold>85</bold>: 201-2. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1002/cyto.a.22441" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/cyto.a.22441</a></pub-id>
  9. Krebs MG, Hou J-M, Sloane R, Lancashire L, Priest L, Nonaka D, <em>et al</em>. Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches. <em>J Thorac Oncol</em> [Internet]. 2012; <bold>7</bold>: 306-15.
  10. Zhao Z, Xu L, Shi X, Tan W, Shangguan D. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells. <em>Analyst</em> 2009; <bold>134</bold>: 1808-14. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1039/B904476K" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1039/B904476K</a></pub-id>
  11. Jimenez E, Sefah K, Lopez-Colon D, Van Simaeys D, Chen HWi, Tockman MS, <em>et al</em>. Generation of lung adenocarcinoma DNA aptamers for cancer studies. <em>PLoS One</em> 2012; <bold>7</bold>: 1-7. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1371/journal.pone.0046222" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1371/journal.pone.0046222</a></pub-id>
  12. Zamay GS, Kolovskaya OS, Zamay TN, Glazyrin YE, Krat AV, Zubkova O, <em>et al</em>. Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood. <em>Mol Ther</em> 2015; <bold>23</bold>: 1486-96. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/mt.2015.108" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/mt.2015.108</a></pub-id>
  13. Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, <em>et al</em>. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines. <em>PLoS One</em> 2013; <bold>8</bold>: e57020. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1371/journal.pone.0057020" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1371/journal.pone.0057020</a></pub-id>
  14. Yan X, Luo H, Zhou X, Zhu B, Wang Y, Bian X. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines. <em>Oncol Rep</em> 2013; <bold>30</bold>: 2733-40. <pub-id pub-id-type="doi"><a href="https://doi.org/10.3892/or.2013.2784" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3892/or.2013.2784</a></pub-id>
  15. Daniels DA, Chen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. <em>Proc Natl Acad Sci U S A</em>.; <bold>100</bold>: 15416-21. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1073/pnas.2136683100" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1073/pnas.2136683100</a></pub-id>
  16. Giordano RJ, Cardó-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. <em>Nat Med</em> 2001; <bold>7</bold>: 1249-53. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1038/nm1101-1249" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/nm1101-1249</a></pub-id>
  17. Telez A, Rubinstein P. Rapid method for separation of blood cells. <em>Transfusion</em> 1970; 10: 223-5. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1111/j.1537-2995.1970.tb00733" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/j.1537-2995.1970.tb00733</a></pub-id>
  18. Nascimento IC, Nery AA, Bassaneze V, Krieger JE, Ulrich H. Applications of aptamers in flow and imaging cytometry. <em>Methods Mol Biol</em> 2016; <bold>1380</bold>: 127-34. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/978-1-4939-3197-2_10" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-1-4939-3197-2_10</a></pub-id>
  19. Bailey TL, Johnson J, Grant CE, Noble WS. The MEME suite. <em>Nucleic Acids Res</em> 2015; <bold>43</bold>: W39-49. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/nar/gkv416" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/nar/gkv416</a></pub-id>
  20. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular evolutionary genetics analysis version 6.0. <em>Mol Biol Evol</em> 2013; <bold>30</bold>: 2725-9. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1093/molbev/mst197" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/molbev/mst197</a></pub-id>
  21. Markham NR, Zuker M. UNAFold: Software for nucleic acid folding and hybridization. <em>Methods Mol Biol</em> 2008; <bold>453</bold>: 3-31. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1007/978-1-60327-429-6_1" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/978-1-60327-429-6_1</a></pub-id>
  22. Kinghorn AB, Fraser LA, Tanner JA. Aptamer bioinformatics. <em>Int J Mol Sci</em> 2017; <bold>pii: E2561</bold>. <pub-id pub-id-type="doi"><a href="https://doi.org/10.3390/ijms18122516" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/ijms18122516</a></pub-id>
  23. Berghmans T, Pasleau F, Paesmans M, Bonduelle Y, Cadranel J, Toth IC, <em>et al</em>. Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations. <em>Eur Respir J</em> 2012; <bold>39</bold>: 9-28. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1183/09031936.00190310" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1183/09031936.00190310</a></pub-id>
  24. Eberhard DA, Giaccone G, Johnson BE. Biomarkers of response to epidermal growth factor receptor inhibitors in non-small-cell lung cancer working group: standardization for use in the clinical trial setting. <em>J Clin Oncol</em> 2008; <bold>26</bold>: 983-94. <pub-id pub-id-type="doi"><a href="https://doi.org/10.1200/JCO.2007.12.9858" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JCO.2007.12.9858</a></pub-id>
DOI: https://doi.org/10.2478/raon-2018-0014 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 152 - 159
Submitted on: Nov 24, 2017
Accepted on: Feb 26, 2018
Published on: Mar 25, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2018 Mateja Vidic, Tina Smuc, Nika Janez, Michael Blank, Tomaz Accetto, Jan Mavri, Isis C. Nascimento, Arthur A. Nery, Henning Ulrich, Tamara T. Lah, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.